New research examines the emerging benefits and unanswered questions surrounding this rapidly expanding class of medications. Millions of people are now using GLP-1 receptor agonists and dual agonists to treat obesity and other metabolic diseases, giving researchers a much broader view of what these medications can do beyond their intended effects. An editorial by Dr. [...]